Astellas Pharma Inc 2021 Annual Report with Sustainability Disclosures
Company: Astellas Pharma Inc
Sector: Manufacturing
Country: Japan
Year: 2021
Type: Annual Report with Sustainability Disclosures
Pages: 205
The report presents Astellas' integrated reporting approach and FY2020 performance for the year ended March 31, 2021. Consolidated revenue was ¥1,249.5 billion, while the environmental action plan targeted a 30% reduction in Scope 1 and Scope 2 GHG emissions by fiscal 2030 from fiscal 2015. The report also states that there were no work-related fatalities in calendar 2020, alongside six injuries requiring leave of absence. These disclosures are supported by groupwide sustainability governance, materiality and employee initiatives.
Services
From bulk PDFs to structured indicators and machine-readable documents.